An Infectious Murine Model for Studying the Systemic Effects of Opioids on Early HIV Pathogenesis in the Gut

Gregory M. Sindberg, Umakant Sharma, Santanu Banerjee, Vidhu Anand, Raini Dutta, Chao Jiang Gu, David J. Volsky, Sabita Roy

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Opioids are known to exacerbate HIV pathogenesis, however current studies have been limited by models of HIV infection. Given that HIV causes many systemic effects via direct infection of host cells as well as indirect bystander effects, it is important to establish a systemic infection model in a small animal so that genetic tools can be utilized to elucidate the mechanisms of action. In this study, the systemic effects of EcoHIV infection, a modified HIV which can infect mouse cells, are examined in conjunction with morphine. EcoHIV infection with opioid treatment induced bacterial translocation from the lumen of the gut into systemic compartments such as liver, which is similar to observations in human patients with LPS. Bacterial translocation corresponds with alterations in gut morphology, disorganization of the tight junction protein occludin, and a concurrent increase in systemic inflammation in both IL-6 and TNFα. Long term infection also had increased expression of inflammatory cytokines in the CNS when co-treated with morphine. Overall, this study shows that EcoHIV is an appropriate model to study the effects of opioids on HIV pathogenesis, including the HIV-induced pathology at early stages of pathogenesis in the gut.

Original languageEnglish (US)
Pages (from-to)74-87
Number of pages14
JournalJournal of NeuroImmune Pharmacology
Volume10
Issue number1
DOIs
StatePublished - Feb 20 2015
Externally publishedYes

Fingerprint

Opioid Analgesics
HIV
Bacterial Translocation
Infection
Morphine
Bystander Effect
Occludin
Tight Junction Proteins
HIV Infections
Interleukin-6
Pathology
Cytokines
Inflammation
Liver
Therapeutics

Keywords

  • Early HIV pathogenesis
  • EcoHIV
  • Gastrointestinal (GI)
  • HIV model
  • Microbial translocation
  • Morphine
  • Opioids

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

An Infectious Murine Model for Studying the Systemic Effects of Opioids on Early HIV Pathogenesis in the Gut. / Sindberg, Gregory M.; Sharma, Umakant; Banerjee, Santanu; Anand, Vidhu; Dutta, Raini; Gu, Chao Jiang; Volsky, David J.; Roy, Sabita.

In: Journal of NeuroImmune Pharmacology, Vol. 10, No. 1, 20.02.2015, p. 74-87.

Research output: Contribution to journalArticle

Sindberg, Gregory M. ; Sharma, Umakant ; Banerjee, Santanu ; Anand, Vidhu ; Dutta, Raini ; Gu, Chao Jiang ; Volsky, David J. ; Roy, Sabita. / An Infectious Murine Model for Studying the Systemic Effects of Opioids on Early HIV Pathogenesis in the Gut. In: Journal of NeuroImmune Pharmacology. 2015 ; Vol. 10, No. 1. pp. 74-87.
@article{7970270ffe454a6283a094079ed026fb,
title = "An Infectious Murine Model for Studying the Systemic Effects of Opioids on Early HIV Pathogenesis in the Gut",
abstract = "Opioids are known to exacerbate HIV pathogenesis, however current studies have been limited by models of HIV infection. Given that HIV causes many systemic effects via direct infection of host cells as well as indirect bystander effects, it is important to establish a systemic infection model in a small animal so that genetic tools can be utilized to elucidate the mechanisms of action. In this study, the systemic effects of EcoHIV infection, a modified HIV which can infect mouse cells, are examined in conjunction with morphine. EcoHIV infection with opioid treatment induced bacterial translocation from the lumen of the gut into systemic compartments such as liver, which is similar to observations in human patients with LPS. Bacterial translocation corresponds with alterations in gut morphology, disorganization of the tight junction protein occludin, and a concurrent increase in systemic inflammation in both IL-6 and TNFα. Long term infection also had increased expression of inflammatory cytokines in the CNS when co-treated with morphine. Overall, this study shows that EcoHIV is an appropriate model to study the effects of opioids on HIV pathogenesis, including the HIV-induced pathology at early stages of pathogenesis in the gut.",
keywords = "Early HIV pathogenesis, EcoHIV, Gastrointestinal (GI), HIV model, Microbial translocation, Morphine, Opioids",
author = "Sindberg, {Gregory M.} and Umakant Sharma and Santanu Banerjee and Vidhu Anand and Raini Dutta and Gu, {Chao Jiang} and Volsky, {David J.} and Sabita Roy",
year = "2015",
month = "2",
day = "20",
doi = "10.1007/s11481-014-9574-9",
language = "English (US)",
volume = "10",
pages = "74--87",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - An Infectious Murine Model for Studying the Systemic Effects of Opioids on Early HIV Pathogenesis in the Gut

AU - Sindberg, Gregory M.

AU - Sharma, Umakant

AU - Banerjee, Santanu

AU - Anand, Vidhu

AU - Dutta, Raini

AU - Gu, Chao Jiang

AU - Volsky, David J.

AU - Roy, Sabita

PY - 2015/2/20

Y1 - 2015/2/20

N2 - Opioids are known to exacerbate HIV pathogenesis, however current studies have been limited by models of HIV infection. Given that HIV causes many systemic effects via direct infection of host cells as well as indirect bystander effects, it is important to establish a systemic infection model in a small animal so that genetic tools can be utilized to elucidate the mechanisms of action. In this study, the systemic effects of EcoHIV infection, a modified HIV which can infect mouse cells, are examined in conjunction with morphine. EcoHIV infection with opioid treatment induced bacterial translocation from the lumen of the gut into systemic compartments such as liver, which is similar to observations in human patients with LPS. Bacterial translocation corresponds with alterations in gut morphology, disorganization of the tight junction protein occludin, and a concurrent increase in systemic inflammation in both IL-6 and TNFα. Long term infection also had increased expression of inflammatory cytokines in the CNS when co-treated with morphine. Overall, this study shows that EcoHIV is an appropriate model to study the effects of opioids on HIV pathogenesis, including the HIV-induced pathology at early stages of pathogenesis in the gut.

AB - Opioids are known to exacerbate HIV pathogenesis, however current studies have been limited by models of HIV infection. Given that HIV causes many systemic effects via direct infection of host cells as well as indirect bystander effects, it is important to establish a systemic infection model in a small animal so that genetic tools can be utilized to elucidate the mechanisms of action. In this study, the systemic effects of EcoHIV infection, a modified HIV which can infect mouse cells, are examined in conjunction with morphine. EcoHIV infection with opioid treatment induced bacterial translocation from the lumen of the gut into systemic compartments such as liver, which is similar to observations in human patients with LPS. Bacterial translocation corresponds with alterations in gut morphology, disorganization of the tight junction protein occludin, and a concurrent increase in systemic inflammation in both IL-6 and TNFα. Long term infection also had increased expression of inflammatory cytokines in the CNS when co-treated with morphine. Overall, this study shows that EcoHIV is an appropriate model to study the effects of opioids on HIV pathogenesis, including the HIV-induced pathology at early stages of pathogenesis in the gut.

KW - Early HIV pathogenesis

KW - EcoHIV

KW - Gastrointestinal (GI)

KW - HIV model

KW - Microbial translocation

KW - Morphine

KW - Opioids

UR - http://www.scopus.com/inward/record.url?scp=84925460927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925460927&partnerID=8YFLogxK

U2 - 10.1007/s11481-014-9574-9

DO - 10.1007/s11481-014-9574-9

M3 - Article

C2 - 25502600

AN - SCOPUS:84925460927

VL - 10

SP - 74

EP - 87

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 1

ER -